LIFECORE BIOMEDICAL, INC. Unamortized Loan Commitment and Origination Fees and Unamortized Discounts or Premiums
LIFECORE BIOMEDICAL, INC. (LFCR) had Unamortized Loan Commitment and Origination Fees and Unamortized Discounts or Premiums of $1.30 million as of 2012-08-26, per its 10-Q/A filed 2013-01-02.
Discontinued › Notes › Credit Losses
us-gaap:UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums · last filed 2013-01-04
- 2012-08-26: Unamortized Loan Commitment and Origination Fees and Unamortized Discounts or Premiums $1.30M.
- 2012-05-27: Unamortized Loan Commitment and Origination Fees and Unamortized Discounts or Premiums $139.00K.
| Period end | Unamortized Loan Commitment and Origination Fees and Unamortized Discounts or Premiums |
|---|---|
| 2012-08-26 | $1.30M 10-Q/A · filed 2013-01-02 |
| 2012-05-27 | $139.00K 10-Q · filed 2013-01-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |